Dou-Mei Wang

Title: Dou-Mei Wang: Innovator in Monoclonal Antibodies

Introduction

Dou-Mei Wang is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. With a total of 2 patents, Wang's research focuses on the detection of specific microorganisms in the oral cavity.

Latest Patents

Wang's latest patents include the development of a hybridoma cell line and monoclonal antibodies targeting Treponema species. One of his key inventions is a monoclonal antibody to Treponema denticola JD-1 and Treponema species 10A, along with a continuous cell line for its production. These antibodies are particularly useful in immunoassays for detecting the presence of these microorganisms in the oral cavity. Another significant patent involves a monoclonal antibody to Treponema denticola ATCC 33520, which also includes a continuous cell line for its production, enhancing the ability to identify these microorganisms effectively.

Career Highlights

Wang is currently associated with Warner-Lambert Company, where he continues to advance his research in immunology. His work has been instrumental in developing tools that aid in the detection of oral pathogens, contributing to better health outcomes.

Collaborations

Wang has collaborated with notable colleagues, including Linda D Sturdivant and Thomas A Biemer. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field.

Conclusion

Dou-Mei Wang's contributions to the field of immunology through his patents on monoclonal antibodies demonstrate his commitment to advancing medical science. His work not only aids in the detection of oral microorganisms but also showcases the importance of innovation in healthcare.